Cargando…

Gavi HPV Programs: Application to Implementation

Developing countries disproportionately suffer from the burden of cervical cancer yet lack the resources to establish systematic screening programs that have resulted in significant reductions in morbidity and mortality in developed countries. Human Papillomavirus (HPV) vaccination provides an oppor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanson, Celina M., Eckert, Linda, Bloem, Paul, Cernuschi, Tania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494350/ https://www.ncbi.nlm.nih.gov/pubmed/26343194 http://dx.doi.org/10.3390/vaccines3020408

Ejemplares similares

Challenges to sustainable immunization systems in Gavi transitioning countries
por: Cernuschi, Tania, et al.
Publicado: (2018)

Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects
por: Botwright, Siobhan, et al.
Publicado: (2017)

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
por: Burger, Emily A., et al.
Publicado: (2018)

Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
por: Kamya, Carol, et al.
Publicado: (2016)

Lessons Learned From Implementing Prospective, Multicountry Mixed-Methods Evaluations for Gavi and the Global Fund
por: Carnahan, Emily, et al.
Publicado: (2020)

The GAVI Alliance and the ‘Gates approach’ to health system strengthening
por: Storeng, Katerini T.
Publicado: (2014)

Mapping of Pro-Equity Interventions Proposed by Immunisation Programs in Gavi Health Systems Strengthening Grants
por: Ducharme, Joelle, et al.
Publicado: (2023)

National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects
por: Tsu, Vivien D., et al.
Publicado: (2021)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

GAVI supply chain strategy people and practice evidence review
por: Steele, Pamela
Publicado: (2014)

Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluation
por: Le, Phuc, et al.
Publicado: (2016)

How to evaluate the implementation of complex health programmes in low-income settings: the approach of the Gavi Full Country Evaluations
por: Soi, Caroline, et al.
Publicado: (2020)

Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
por: Russell, Allyson L, et al.
Publicado: (2023)

Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden
por: Kim, Sun-Young, et al.
Publicado: (2011)

Challenges to implementing Gavi’s health system strengthening support in Chad and Cameroon: results from a mixed-methods evaluation
por: Dansereau, Emily, et al.
Publicado: (2017)

All Health Partnerships, Great and Small: Comparing Mandated With Emergent Health Partnerships: Comment on "Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda"
por: Green, Elaine, et al.
Publicado: (2017)

Exploring the influence of the Global Fund and the GAVI Alliance on health systems in conflict-affected countries
por: Patel, Preeti, et al.
Publicado: (2015)

Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries
por: Saxenian, Helen, et al.
Publicado: (2015)

Resource Allocation Strategies to Increase the Efficiency and Sustainability of Gavi’s Health System Strengthening Grants
por: Mimche, Honoré, et al.
Publicado: (2018)

Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction
por: Soble, Adam, et al.
Publicado: (2020)

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019)

Strengthening immunisation supply chain systems through the GAVI Alliance Immunisation Supply Chain Strategy
por: Brownlow, Kaleb, et al.
Publicado: (2014)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy
por: Prosser, Wendy, et al.
Publicado: (2022)

Evaluating Country Performance After Transitioning From Gavi Assistance: An Applied Synthetic Control Analysis
por: Kolesar, Robert John, et al.
Publicado: (2023)

Passed the Age of Puberty: Organizational Networks as a Way to Get Things Done in the Health Field: Comment on "Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda"
por: Kenis, Patrick
Publicado: (2017)

Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999–2014)
por: Gandhi, Gian
Publicado: (2015)

Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support
por: Ferrinho, Paulo, et al.
Publicado: (2013)

The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
por: Baral, Ranju, et al.
Publicado: (2020)

Advancing Immunization Coverage and Equity: A Structured Synthesis of Pro-Equity Strategies in 61 Gavi-Supported Countries
por: Ivanova, Vesela, et al.
Publicado: (2023)

Implementation of a targeted HPV educational program in a population with HIV
por: Ayoub, Noel, et al.
Publicado: (2019)

Advantages and disadvantages of channeling Gavi’s health system strengthening funds through health partners, a case study
por: El Bcheraoui, Charbel, et al.
Publicado: (2018)

The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study
Publicado: (2019)

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya
por: Ojal, John, et al.
Publicado: (2019)

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2019)

Has Gavi lived up to its promise? Quasi-experimental evidence on country immunisation rates and child mortality
por: Jaupart, Pascal, et al.
Publicado: (2019)

Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low‐ and lower‐middle‐income countries
por: Kumar, Somesh, et al.
Publicado: (2020)

Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study
por: Birger, Ruthie, et al.
Publicado: (2022)

The Implementation of a Primary HPV Self-Testing Cervical Screening Program in Malaysia through Program ROSE—Lessons Learnt and Moving Forward
por: Woo, Yin Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qbo3rhfpfq2sm1h9msk6657prv